In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.

As the fires of the American opioid crisis continue to burn, can new painkillers step in?

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

We explore the potential of mRNA as therapeutics and the challenges associated with analysis and sequencing.

With so many new dosage forms being seen in pharma, a problem is emerging: the need for novel excipients. Watch our video to learn more.

We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.

How SaudiVax is partnering to help patients in the Middle East and Africa to access advanced medicine.

How work on sharks could provide a highly effective weapon against new COVID variants

How a deep-learning approach can help improve the quality of cell imaging.

A short guide to strengthening raw materials supply chains in the biopharma industry, featuring Luis Bianchi Pintos from Thermo Fisher Scientific.